Wells Fargo Maintains Equal-Weight on Amphastar Pharma, Raises Price Target to $25

Benzinga · 1d ago
Wells Fargo analyst Benjamin Burnett maintains Amphastar Pharma (NASDAQ:AMPH) with a Equal-Weight and raises the price target from $20 to $25.